Diabifence PG 2mg/500mg/15mg Tablet
Marketer
Gelmek Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Diabifence PG 2mg/500mg/15mg Tablet
GlycemiaControl TX 2mg/500mg/15mg tablets offer a triple-action approach to managing blood glucose. This medication, used in conjunction with diet and exercise, assists adults with type 2 diabetes in achieving better glycemic control. It enhances insulin effectiveness, consequently reducing blood sugar. Dosage and duration for GlycemiaControl TX 2mg/500mg/15mg tablets should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; exceeding the prescribed amount risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals elevates the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, individuals with kidney, liver, or heart conditions should inform their doctor. Pregnant or lactating women require medical consultation before use. Baseline kidney function tests are typically conducted before initiating therapy. Limit alcohol consumption, as increased intake may heighten the risk of adverse events.
Primary Ingredients of Diabifence PG 2mg/500mg/15mg Tablet
No text provided to rephrase.
Uses of Diabifence PG 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Diabifence PG 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Diabifence PG 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Diabifence PG 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Diabifence PG 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Diabifence PG 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Diabifence PG 2mg/500mg/15mg Tablet works:
Diabifence PG 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Diabifence PG 2mg/500mg/15mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Diabifence PG 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Diabifence PG 2mg/500mg/15mg tablets are likely incompatible. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Diabifence PG 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Diabifence PG 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Diabifence PG 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Diabifence PG 2mg/500mg/15mg Tablet :
Should you forget to take your Diabifence PG 2mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Diabifence PG 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently